balapiravir [RO4588161]
PP22799
Phase 1 small_molecule completed
Quick answer
balapiravir [RO4588161] for Dengue is a Phase 1 program (small_molecule) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hoffmann-La Roche
- Indication
- Dengue
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed